I. Mcgrogan et Ee. Daniel, RELEASE AND ACTIONS OF INHIBITORY PROSTAGLANDINS FROM CANINE TRACHEALEPITHELIUM, Canadian journal of physiology and pharmacology, 74(9), 1996, pp. 1055-1060
This study evaluated the sources and actions of inhibitory prostanoids
on canine tracheal smooth muscle to determine if these accounted for
epithelium derived relaxing factor activity. Concentration-response cu
rves of canine tracheal smooth muscle were generated to carbachol in t
he presence and absence of the epithelium and (or) indomethacin, a cyc
looxygenase inhibitor. Removal of the epithelium or addition of indome
thacin (10(-5) M) in the presence of the epithelium shifted the curve
significantly leftward compared with epithelial-intact tissue. Further
more, addition of indomethacin to epithelial-denuded tissue produced t
he greatest shift in the curve. Removal of the epithelium increased co
ntractility in response to electrical-field stimulation at intermediat
e frequencies compared with epithelium-intact tissues. The addition of
indomethacin to epithelium-intact tissue also increased the contracti
le responses. Removal of the epithelium in the presence of indomethaci
n further increased responses. Radioimmunoassay of muscle bath fluid i
ndicated that the inhibitory prostanoids prostaglandin I-2 (PGI(2)) an
d prostaglandin E(2) (PGE(2)) were released. PGI(2) was released from
the epithelium as well as from a nonepithelial source. PGE(2) was rele
ased from the epithelium in response to electrical-field stimulation.
The release of PGE(2) was greatly reduced by the addition of indometha
cin (10(-5) M), but not by the addition of omega-conotoxin (GVIA), an
N-type Ca2+ channel antagonist, nor by the addition of tetrodotoxin, a
Na+ channel blocker. Both toxins abolished contractions to electrical
-field stimulation. We conclude that the inhibitory prostanoids PGI(2)
and PGE(2) are released, along with a nonprostanoid factor from epith
elium, and modulate airway smooth muscle contractility to stimulation
of cholinergic nerves and muscarinic agonists. PGE(2) is released from
epithelium by electrical-field stimulation independent of nerve funct
ion.